Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2026-02-21 @ 9:03 AM
Study NCT ID:
NCT03947866
Status:
UNKNOWN
Last Update Posted:
2023-02-16
First Post:
2019-05-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ezetimibe-Rosuvastatin Evaluation Study
Sponsor:
Elpen Pharmaceutical Co. Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2022-ROSEZE-EL-160
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None